Reimbursement
The AHA Aug. 13 commented to the Medicare Payment Advisory Commission in anticipation of the commission’s 2024-2025 cycle.
AHA statement on policies to ensure rural patients continue to receive access to high-quality care.
The AHA’s new Costs of Caring report highlights how hospitals and health systems continue to experience significant financial pressures that challenge their ability to provide 24/7 care for patients and communities.
It is broadly acknowledged that Medicare reimburses hospitals less than the cost of providing care and their reimbursement rates are non-negotiable.
The AHA May 2 released a new report highlighting how hospitals and health systems continue to experience significant financial pressures that challenge their ability to provide 24/7 care for patients and communities.
The AHA and American Society of Health-System Pharmacists Nov. 14 urged House and Senate leaders to oppose any policies that fail to take into account the costs of safely providing drug administration services to the complex patients that hospitals serve.
AHA comments on the CMS' proposed Notice of Benefit and Payment Parameters for 2024.
The Centers for Medicare & Medicaid Services (CMS) Nov. 1 issued its physician fee schedule (PFS) final rule for calendar year (CY) 2023.
The Centers for Medicare & Medicaid Services (CMS) on Nov. 1 posted its calendar year (CY) 2023 outpatient prospective payment system (OPPS)/ambulatory surgical center (ASC) final rule. The rule increases OPPS rates by a net 3.8% in CY 2023 compared to 2022.
The United States District Court for the District of Columbia ruled in favor of the AHA, holding that HHS must immediately halt the departments’ unlawful cuts to outpatient reimbursement rates for the remainder of 2022 for certain hospitals that participate in the 340B Drug Pricing Program.